Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

AF10 Fusion Transcripts Are Identified By HOXA9/10 and MEIS1 Overexpression In T-ALL: A Report From Children’s Oncology Group AALL0434

Ksenia Matlawska-Wasowska, PhD, Richard C. Harvey, PhD, Nyla A. Heerema, PhD, Andrew J. Carroll, PhD, Meenakshi Devidas, PhD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Elizabeth A. Raetz, MD, Charles G. Mullighan, MBBS, MSc, MD, FRACP, FRCPA, Naomi J. Winick, MD, William L. Carroll, MD, Richard S. Larson, MD, PhD, Kimberly Dunsmore, MD, Peter D. Aplan, MD, Stuart S. Winter, MD

Blood (2013) 122 (21): 2601.

https://doi.org/10.1182/blood.V122.21.2601.2601

Published: 2013

Journal Articles

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Jinghui Zhang, PhD, Li Ding, PhD, Linda Holmfeldt, PhD, Gang Wu, PhD, Susan L. Heatley, Ph.D., Debbie Payne-Turner, John Easton, PhD, Xiang Chen, PhD, Jianmin Wang, PhD, Michael Rusch, BA, Charles Lu, PhD, Shann-Ching Chen, PhD, Racquel Collins-Underwood, PhD, Jing Ma, PhD, Kathryn G. Roberts, PhD, Stanley Pounds, PhD, Lei Wei, PhD, Anatoly Ulyanov, PhD, Jared Becksfort, Pankaj Gupta, Robert Huether, PhD, Richard Kriwacki, PhD, Daniel McGoldrick, David Zhao, Daniel Alford, Stephen Espy, Kiran Chand Bobba, Guangchun Song, Deqing Pei, MS, Cheng Cheng, PhD, Stefan Roberts, Michael Barbato, Dario Campana, MD, PhD, Elaine Coustan-Smith, MS, William E. Evans, PharmD, Sheila A Shurtleff, PhD, Maria Kleppe, Jan Cools, PhD, Kristin Shimano, Michelle L. Hermiston, MD, PhD, Sergei Doulatov, PhD, Kolja Eppert, PhD, Elisa Laurenti, PhD, Faiyaz Notta, PhD, John E Dick, PhD, Giuseppe Basso, MD PhD, Stephen P. Hunger, MD, Mignon L Loh, MD, Meenakshi Devidas, PhD, Brent L. Wood, MD, PhD, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Robert S. Fulton, MS, Lucinda A. Fulton, MS, Xin Hong, PhD, Christopher C. Harris, BS, David J. Dooling, PhD, Kerri Ochoa, Kimberly J Johnson, John C Obenauer, Ching-Hon Pui, MD, Susana C. Raimondi, PhD, Clayton W Naeve, PhD, Timothy J Ley, MD, Elaine R Mardis, PhD, Richard K Wilson, PhD, James R Downing, MD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc

Blood (2011) 118 (21): 68.

https://doi.org/10.1182/blood.V118.21.68.68

Published: 2011

Journal Articles

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

David Wu, MD, PhD, Anna Sherwood, PhD, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Mignon L Loh, MD, Jonathan R Fromm, MD, PhD, Harvey A Greisman, MD, PhD, Daniel E. Sabath, MD, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2011) 118 (21): 2545.

https://doi.org/10.1182/blood.V118.21.2545.2545

Published: 2011

Journal Articles

High-Throughput Screening by Flow Cytometry Identifies Reduced Expression of CD48 As a Universal Characteristic of T-ALL and a Suitable Target for Minimal Residual Disease (MRD) Detection

Brent L. Wood, MD, PhD, Greg Levin, MT, Megan Wilson, MT, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Mignon L Loh, MD, Michael J. Borowitz, MD, PhD

Blood (2011) 118 (21): 2547.

https://doi.org/10.1182/blood.V118.21.2547.2547

Published: 2011

Journal Articles

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Stuart S. Winter, MD, Meenakshi Devidas, PhD, Brent Wood, MD, PhD, Michael J. Borowitz, MD, PhD, Mignon L. Loh, M.D., Barbara Asselin, MD, John Murphy, Elizabeth Raetz, MD, Naomi Winick, MD, Stephen Hunger, MD, William Carroll, MD, Kimberly Dunsmore, MD

Blood (2010) 116 (21): 865.

https://doi.org/10.1182/blood.V116.21.865.865

Published: 2010

Journal Articles

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

Brent Wood, MD, PhD, Stuart Winter, MD, Kimberly Dunsmore, MD, Elizabeth Raetz, MD, Michael J. Borowitz, MD, PhD, Meenakshi Devidas, PhD, Naomi J. Winick, MD, William L. Carroll, MD, Stephen P Hunger, MD, Mignon L. Loh, MD

Blood (2009) 114 (22): 9.

https://doi.org/10.1182/blood.V114.22.9.9

Published: 2009

Journal Articles

Precursor T Cell Acute Lymphoblastic Leukemia (T-ALL) Blasts Lose Expression of Markers of Immaturity during Chemotherapy: Implications for the Detection of Minimal Residual Disease.

Mikhail Roshal, MD, PhD, Jonathan Fromm, MD, PhD, Stuart Winter, MD, Kimberly Dunsmore, MD, Brent Wood, MD, PhD

Blood (2008) 112 (11): 1521.

https://doi.org/10.1182/blood.V112.11.1521.1521

Published: 2008

Journal Articles

Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.

Kimberly Dunsmore, MD, Meenakshi Devidas, Phd, Michael J. Borowitz, MD, Naomi Winick, MD, Stephen Hunger, MD, William L. Carroll, MD, Bruce Camitta, MD

Blood (2006) 108 (11): 1864.

https://doi.org/10.1182/blood.V108.11.1864.1864

Published: 2006

NARROW

AF10 Fusion Transcripts Are Identified By HOXA9/10 and MEIS1 Overexpression In T-ALL: A Report From Children’s Oncology Group AALL0434

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

High-Throughput Screening by Flow Cytometry Identifies Reduced Expression of CD48 As a Universal Characteristic of T-ALL and a Suitable Target for Minimal Residual Disease (MRD) Detection

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

Precursor T Cell Acute Lymphoblastic Leukemia (T-ALL) Blasts Lose Expression of Markers of Immaturity during Chemotherapy: Implications for the Detection of Minimal Residual Disease.

Nelarabine Can Be Safely Incorporated into an Intensive, Multiagent Chemotherapy Regimen for the Treatment of T-Cell Acute Lymphocytic Leukemia (ALL) in Children: A Report of the Children’s Oncology Group (COG) AALL00P2 Protocol for T-Cell Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only